we're given first on an today longer good good be you, that, you XXXX effort safe Hope apologize quarter crisis, us my a morning, earnings the our what on and narratives color I in well. in Thank amount provide in a ground. is I advance call. little Thanks the to will seeing of for joining want and everyone on to Andrew, everyone.
don't as our Of after available course, to quarter have Today, review will performance. to your questioning, time team always, if get is answer we questions first we the our call. to
for We also and light guidance quarter guidance COVID-XX. provide full the update second will in our of year
First, review the precrisis challenges been a months. with couple team. management instituted that been we've day every let's leadership structure we I've ensure to how priorities navigating on over the my We've align the senior last organization. meeting across of
agile centered to decisive As collectively, the disclosed, priorities. we're response and be and communication in to our has crisis, us currently allowed around four
frequently health of the facilities all travel, suppliers infrastructure of of and added to most To First, remote course, We've disruptions. with avoid to supplied customers, bandwidth service field-based exposure, patients, whom employees, to working safety our our and we advanced prohibited we interact. staff have VPN work professionals, to our employees, remotely. closed substantially care PPE limit enable capacity
mitigate difficult remote possible, the safety. the they disruptions travel, trials hospitals and ensure visits been patients to do to in our we've transitioning monitoring monitoring number inaccessible remote have we reaching of has everything continued clinics to to for or patient as unsafe level become Second, with Xx crisis. have to to Wherever power and become the were clinical prior and
trial such CRAs, patients telehealth we've activities our Study contact but enabling been and delivery platform. we could, could Perhaps existing Hub, between our drug whenever We and trials to health ensure we as draws. at-home leveraged transitioning -- portions and of lab been investigator, home continuity to have services for visits virtual of we've
for other deploying manage and and Third, the to we're plan help capabilities. outbreak, our organizations clients our unique
the help our are we our manage disease, and and to bring capacity to chains. progression insights and of technology applying AI supply monitor the data people, example, clients For track
We and to market weekly outbreak them leadership to tracking actively white reports, will things understand clients help through papers, predict pieces engaged how thought the X dynamics are webinars and of develop. briefings, executive the regular with rapidly evolving
the resources week, to our Department to joined Finally, of response resolution. the in Office crisis of global example, U.K., have National and Asia, joining commenced for for immunity. U.K. Health, developed behalf testing the the we we're Statistics, with contributing team Last on we the U.K. of immediately provided and countrywide of households Oxford treatments to an We In develop existing infection University Biocentre. tests. and COVID-XX a the IQVIA program to University to and experimental HIV vaccine vaccine vaccines. with U.S. industry lab U.S., partnering quicker line. for currently using accelerate available new COVID-XX candidates several data site X we prime Europe, develop tests identify are assets and In new we're Texas with candidates the of collaborating to flu to time and and the In than our the networks using its governments
more trials talk will later. COVID-XX vaccines, and multiple for of which are, involved We therapeutics in about course, I
During innovate. researchers This at this matching projects within research clinical to Two our COVID-XX will to team cXXtrials.com. at-risk ago, ongoing connect COVID-XX the we R&D launched time, platform trial technology-enabled weeks critical continue online solution first the individuals U.S. and
vast treat sharing IQVIA In analytics to to disease. and understand If Project certain stakeholders the to apply successful, prevent treatments connect the all team much in these Real-World and information better experience advance how patients. the addition, registry. with registries will The bring the to platform help of launched CARE our will and
from Client on note, differentiated their our is of look review to the impacts ability strong remain virus of by own demand important the offerings all a as let's the projects of results quarter, Now operational segments, move to we before even in I'll temporary. or hampered forward to virus. interest caused take some our business across at the our if delayed. the and view is impacts the It
In life impacted impacted. of part cycle. are most Site clinical also patient start-up recruitment have visits R&DS, site been the monitoring the trial
our accessible of for monitoring XX% are only global sites visits. CRAs our today, to of As currently on-site
are collection little activities with reporting data On more regulatory the continuing less or other interruption. hand, and
For and centralized increase services technologies and we local deploy, health monitoring CRA authorities for remote further in-site and customers are when to patient and trials closely feasible, to trials, our coordinating with and visits. appropriate remote-based
As require visits. remote site documentation, would of are eCOA on-site constrained, in the the will When not vast et for seeing to of safely connected virtual to anticipate and an most that additional crisis satisfy have checking the go cetera, perform devices. demand we trials, the that we trials, above during task performed trials But majority, substantially, subsides, crisis. require the other and the CRAs we access and work requirements uptick e-consent, over minimal remains some will
remained activity R&D has strong. business development
qualified some We for cancellation. at remains are been record with line which not COVID-related in had example, single year, interactions holding a with record XXXX, pushed have Face-to-face high. strong with getting a to and Big delayed are is activity have our RFPs levels a defenses, the new clients challenge. at pipeline was right. business obvious that the
In interruptions no or Technology & data had in we Analytics, demand. supply
production remains portion said, decisions interactions conferences in-person the has operational deliveries course. are been activity Conversely, been situation. and activity, centers & impacted. Real-World experiencing The continue face-to-face relatively Analytics proportion prospective due in insulated. also business of dependent fully gathering of hampered rely That are remain as Our of our the on delayed are events business on higher in that the or or Technology data parts however, requires to development disruption. that has our well the given somewhat site segment, revenue the recurring being monitoring Business it the ordinary TAS
commercial quarter. not the much did are the subside an not see significant first as at in in footprint stage. the Finally, of in And have alter that impact and cancellations is any their crisis this clients near that to term, seen we anticipation result, CSMS happening here what's a will reluctant
trying We services and are, remotely virtual through also to e-detailing of meetings. course, deliver
and, a delayed activity However, flow. more attention due COVID-XX focused due of in physician to challenging and sales become in to also course, focused attention decision-making -- has much reduced being the decline being CSMS crisis. Business become challenging visits physical has development on RFP rep
up at growth the essentially Solutions we services Contract quarter Now we a billion than beat anticipated. $X.XXX $X.XXX in expected. at have a Solutions at billion. first constant backdrop, $XXX headwind recent Constant pass-through, billion, perspective, and segment our Analytics which was came grew the quarter X.X% currency & originally been against and let's Technology higher the than by X.X% points, slightly as currency, of currency, $X.XXX mostly in at excluding was in first revenue over came & was Sales revenue a pass-through growth most million was Medical The R&D range. X.X%. From guidance revenue Revenue driven quarter higher in basis results. Solutions constant XXX little was review would came and this approximately X%. for have
and was EBITDA quarter was $X.XX. adjusted quarter First diluted $XXX million adjusted first EPS
which bookings standard, especially was want impressive by R&DS, backdrop. I growth broader Now highlight to given any but the in so
including including year-over-year compared the contracted backlog, first first X.XX across XXXX. pass-throughs contracted LTM the XX X.XX contracted March excluding pass-throughs. net X.XX including quarter book-to-bill book-to-bill was March business, for pass-throughs, quarter was XX% of The XX, pass-throughs, board. contracted pass-throughs, excluding new business business was billion XX at The new strong was In quarter LTM first ratio book-to-bill new pass-throughs, X.X% the -- net awards quarter, First net end XXXX. and last the the ratio, at including year. of at March at And up to to X.XX. contracted was grew business and $XX.X LTM
vaccine of The contracted of COVID-XX which first number quarter, in just backlog awarded are and course, I trial mentioned. of not that a treatment our most the bookings or team was, during
and other a working treatments currently between XX pipeline we XX fact, awards In projects. of COVID-XX vaccines, are with potential on
these projects course, discounted. are heavily generally Of
much are so won't contributing effort against bookings. of they the our COVID-XX general represent to We
significant a uniquely and including is design, using to IQVIA with Importantly, customers. sponsorship many deliver, Real-World trial comparator of of our arm, entail studies several government on transformative positioned behalf which number the these
our industry's will crisis is, dynamics, believe a their fundamental consumer-oriented short-cycle not loss the some It ever. better than our in As We dramatic are all or due as revenue know I for eventually will fact, industries to and of change prospects nature. subside. it permanent experience industry will this
However, pushed right. needs work pipeline. due a the long-term In we pharma our and being to of backlog case, are got into critical our serving our business just the business long-cycle the to is We've good visibility industry.
critical discovery. how to of a This will pharmaceutical no viable reminder require Patients substitution for the medicines new and crisis innovative is industry to society. continue is is drug
to an our treatments clients role in to helping bring enormous have We life-saving patients. play
more at diseases. X,XXX For The treated from XXX time, than are more suffer and, example, patients million every more people million cardiovascular disease given million any rare than year, XXX XXX even for technology, patients data, in and oncology, crisis. and become our to accelerate with for evident therapeutic time new this trial advanced need expertise during lines combined customers use to analytics medicines launch to real-world clinical has
relevant before We we our be started. than even will to more customers were the crisis
sure could, us While virus year to suspend the into knows the of of business as will balance is assumptions what current develop, have and XXXX. our looks we a like guidance hopefully the course, well, step navigate point is and the And on business subsides, and view of as But point incumbent snap make disruption. back our back it of uncertain year one and certainly let's crisis what that see happens. about how view of course this the the this say, later to and will we for believe one is no
through future, about the navigate maintaining the assumptions we're on our focused these we capability operational crisis. Given as
vendor actions We've We aggressive in We stopped for with and while leases manage stopped of second we declines estate We've We've and taking renegotiated our revenue are the are, actions ready renewing quick projects. contracts. some quarter. of ensuring our our many control employment in recovery. costs. deferred contracts a similar discretionary of course, to also third-party much to spend line real costs temporary
rebound our best our extent in want we anticipation and, However, are we for to greatest to our to assets, demand to expecting times. the in are stick to in the compensation possible, our services. take can, these base employees. and strong together for of do employment of difficult our for employees need not now, as especially preserve They we we We will as affect much care
of staff. temporary small their We've, time very the a Many business announcing the if significantly, somewhat take are, our make during total to employees, work -- who of with In parts taking nuanced from course, than asked approximately reductions. utilization the our the materially time-off more more we companies and approach. corresponding option from pay time-off broad-based some of very represents difficult recovery proportions a defer. need requested prepared employees assumptions X% to be current less implementing on our drastic this been our where date, people, are workforce. reductions total dropped in significant or time-off. should reality, delayed affecting decisions be of offer prove are In of course, to have of has XXX week. work This reduced either we to different conditions partial pay ground We're Obviously,
rest see compensation now, XX,XXX-plus For the employees reductions. our not of any mandatory-based broad will
distributed as who the from proceeds and XX% with be all a the XX% colleagues to CARE, XX% lower executive CEO. Separately, new for direct those senior temporary will result the by my outbreak. facing reduction These crisis, an SVPs this executive hardships to program are executives COVID-XX to pay for the fund the pay of COVID-XX cuts and affected this IQVIA of quarter cuts pay for for expression family a a program are solidarity launching used from across most voluntary we company launching will ranging pay we're The entirely relief level week. these to be as reports
and leadership XXXX much year units Finally, end-of-summer our earlier I though highlight in based we have engaging to difficult planning organization we have parallel, normally these to of recovery. navigate scenarios our you started This for through the on times, crisis same helping team annual on next activity, in also, time started at are than our is usual. we for already as process planning business the our various and that focused managing an through want end-of-year
the the XXXX earlier year fourth of of at our earnings, guidance year with this guidance annual hope beginning usual. concurrent we provide release usually we the to While quarter provide than
and laid out to the assumptions will quarter for turn the I Now it Mike over detail some for of we've XXXX. the remainder on Mike?
